Position in LQDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$666,944,479
+$340,265,605 QoQ
Shares Held
8,365,038
-3.4% QoQ
Ownership
9.35%
of shares outstanding
% of Portfolio
3.94%
of 13F equity value
Holder Rank
#2
of 334 holders
Holding Since
Jun 2020
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FARALLON CAPITAL MANAGEMENT LLC holds $1,298,300,139 across 5 Drug Manufacturers - Specialty & Generic names. LQDA ranks #1 (51.4% of the industry book) .
All Filings in LQDA
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $666,944,479 | 8,365,038 | Shares | Sole | 2026-08-04 | |
| 2026-06-30 | $666,944,479 | 8,365,038 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $326,678,874 | 8,656,038 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $298,546,750 | 8,656,038 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $194,782,608 | 8,565,638 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $52,814,974 | 4,238,762 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $58,866,601 | 3,990,956 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $38,701,642 | 3,290,956 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $32,909,560 | 3,290,956 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $24,660,000 | 2,055,000 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $30,311,250 | 2,055,000 | Shares | Other | 2024-05-24 | |
| 2020-09-30 | $9,177,522 | 1,865,350 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $15,577,000 | 1,850,000 | Shares | Other | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||